Vehicle TB Staining
More than 480,000 new cases of multi-drug resistant tuberculosis (MDR-TB) were reported worldwide in 2013 , and only 20 percent of MDR-TB patients were enrolled in treatment.
Our agreements and partnerships aim to improve access, advance new treatment regimens and foster responsible access. In 2009, we announced a landmark collaboration with the Global Alliance for TB Drug Development (TB Alliance). In September 2014, we announced that we will be providing a grant to Harvard Medical School to support a two-year research, policy and advocacy program to address significant unmet needs in drug-resistant TB. We will continue to establish additional collaborations with key stakeholders to advance public health goals.